Finance

Beta
Lists
REVB:NASDAQ
Revelation Biosciences Inc
$1.05
0.00%
(0.00) 1D
$1.01
-4.23% (-0.044)
Pre-market
Closed: Jun 23, 4:00:01 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for REVB...
Open
$1.04
High
$1.05
Low
$1.03
Mkt. cap
4.10M
Avg. vol.
56.98K
Volume
146.00
52-wk high
$12.84
52-wk low
$0.88
EPS
-$39.46
Beta
-0.09
Shares outstanding
3.91M
No. of employees
8
Open
$1.04
High
$1.05
Low
$1.03
Mkt. cap
4.10M
Avg. vol.
56.98K
Volume
146.00
52-wk high
$12.84
52-wk low
$0.88
EPS
-$39.46
Beta
-0.09
Shares outstanding
3.91M
No. of employees
8
News stories
From sources across the web
About Revelation Biosciences Inc
CEO-
Employees8
Founded2019
Headquarters-
SectorBiotechnology
Websiterevbiosciences.com
Analyst Ratings
Based on 1 analyst giving stock ratings to REVB in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for REVB in the last 3 months.
Highest
Current $1.05
$16.00 (+1,423.81%)
Average
$16.00 (+1,423.81%)
Lowest
$16.00 (+1,423.81%)
Analyst
Recommendation
Action
Price Target
Projected
Date
Jonathan Aschoff
Roth MKM
Buy
Maintained
$16.00
+1,423.8%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
1.32M
922.86K
964.19K
1.38M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.14M
1.02M
1.61M
1.72M
Operating expense
2.46M
1.94M
2.57M
3.09M
Total operating expenses
2.46M
1.94M
2.57M
3.09M
Operating income
-2.46M
-1.94M
-2.57M
-3.09M
Other non operating income
16.85K
35.84K
60.58K
83.45K
EBT including unusual items
-2.44M
-1.91M
-2.51M
-3.01M
EBT excluding unusual items
-2.44M
-1.91M
-2.51M
-3.01M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-2.44M
-1.91M
-2.51M
-3.01M
Net profit margin
-
-
-
-
Earnings per share
-28.04
-7.08
-1.65
-2.71
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-2.45M
-1.94M
-2.57M
-3.09M
Gain or loss from assets sale
-
4.49K
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer